NCT05415527 - Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 11, 2022

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2028

Conditions

Ovarian Carcinoma

Interventions

OTHER

Presence of sarcopenia evaluated prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management(dietician and APA).

"Sarcopenia will be evaluated by CT-scan. This method will be combined with a bone mineral density test which is also a way of entering into a more specific approach to sarcopenia screening.~The patients will receive optimised treatment by nutritional monitoring and adapted physical activity (APA) in addition to follow-up for sarcopenia."

Trial Locations (1)

Unknown

RECRUITING

Institut Bergonié, Bordeaux